William Ho, President & CEO of IN8Bio, discusses the development of next-generation cancer therapies aimed at transforming patient outcomes. He explains how emerging treatment platforms are advancing the field beyond traditional oncology approaches, with a focus on adaptability, precision, and long-term efficacy. As innovation accelerates, Ho shares insights on what’s driving momentum in cancer research and where therapeutic breakthroughs may come next.
